T1	Outcomes 1303 1330	overall first response rate
T2	Outcomes 1520 1530	myelotoxic
T3	Outcomes 1574 1606	non-haematological side-effects.
T4	Outcomes 1678 1694	disease control.
T5	Outcomes 1695 1717	Progression of disease
T6	Outcomes 1860 1886	duration of first response
T7	Outcomes 2052 2086	median duration of first response.
T8	Outcomes 2091 2119	overall second response rate
T9	Outcomes 2194 2209	Median survival
T10	Outcomes 2424 2432	survival
T11	Outcomes 2680 2694	first response
T12	Outcomes 2704 2719	second response
T13	Outcomes 2794 2807	side effects.
